Chris Rallis
Director/Board Member at AEOLUS PHARMACEUTICALS, INC.
Net worth: 419 876 $ as of 30/04/2024
Network origin in Chris Rallis first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
| Public Company | Pharmaceuticals: Major | 16 | |
| Public Company | Pharmaceuticals: Major | 12 | |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC.
8
| Extinct | Miscellaneous Commercial Services | 8 |
Salisbury School, Inc.
3
| Private Company | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Chris Rallis via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| The University of North Carolina at Charlotte | College/University | Graduate Degree Undergraduate Degree Masters Business Admin Masters Business Admin Undergraduate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Hoechst Marion Roussel, Inc. | Sales & Marketing Corporate Officer/Principal Comptroller/Controller/Auditor | ||
| Wake Forest University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
Phyxius Pharma, Inc.
 Phyxius Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., Phyxius Pharma, Inc. provides pharmaceutical products. The company is based in Chester, NJ. The company was founded by Doug Randall, Douglas Hay, John P. Kelley. Phyxius Pharma was acquired by Life Newco, Inc. on November 13, 2013 for $32.66 million. | Pharmaceuticals: Major | Founder Founder Founder | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Founder Director/Board Member Corporate Officer/Principal | |
| GENTIUM S.P.A. (ADR) | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Comptroller/Controller/Auditor | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Corporate Officer/Principal | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Founder Chief Operating Officer | |
| ANIXA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Xmark Fund Ltd. | Corporate Officer/Principal Chief Investment Officer | ||
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PRECISION BIOSCIENCES, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| VAXART, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Maryland | College/University | Undergraduate Degree Doctorate Degree | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| University of Bath | College/University | Doctorate Degree Undergraduate Degree | |
| University of Milan | College/University | Corporate Officer/Principal Doctorate Degree | |
| DCML LLC | Founder Founder | ||
| REBUS HOLDINGS, INC. | Biotechnology | Corporate Secretary Director/Board Member | |
The Pulmonary Vascular Research Institute
 The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| McManus Financial Consultants, Inc. | Founder Corporate Officer/Principal | ||
| University of South Carolina | College/University | Undergraduate Degree Graduate Degree | |
| Wake Forest School of Medicine | College/University | Doctorate Degree Graduate Degree | |
The Burroughs Wellcome Fund
 The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Investment Trusts/Mutual Funds | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| HMR Pharma, Inc. | Sales & Marketing Comptroller/Controller/Auditor | ||
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Uniformed Services University of the Health Sciences | College/University | Corporate Officer/Principal Doctorate Degree | |
National Jewish Health, Inc.
 National Jewish Health, Inc. Medical/Nursing ServicesHealth Services National Jewish Health, Inc. provides healthcare services. It offers personalized medicines that prevents and treats respiratory, cardiac, immune and related disorders. The company was founded in 1899 and is headquartered in Denver, CO. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
American Thoracic Society, Inc.
 American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Thoracic Society, Inc. is a professional membership organization for thoracic surgeons. The non-profit company is based in New York, NY. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
| Rockhurst University | College/University | Masters Business Admin Masters Business Admin | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Riverside | College/University | Undergraduate Degree | |
Portage Pharma Ltd.
 Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Pharmaceuticals: Major | Founder | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Founder | |
| University of Illinois | College/University | Undergraduate Degree | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 42 |
| United Kingdom | 6 |
| Italy | 3 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 17 |
| Commercial Services | 3 |
| Miscellaneous | 2 |
| Finance | 2 |
Operational
| Director/Board Member | 207 |
| Corporate Officer/Principal | 147 |
| Independent Dir/Board Member | 72 |
| Chief Executive Officer | 66 |
| Chairman | 65 |
Most connected contacts
| Insiders | |
|---|---|
| Khalid Islam | 29 |
| Declan Doogan | 28 |
| Michael Davidson | 27 |
| Daniel Welch | 24 |
| Amit Kumar | 21 |
| Raymond Schinazi | 19 |
| Gerry Proehl | 19 |
| Marco Brughera | 19 |
| Russell Skibsted | 17 |
| Steven Skolsky | 17 |
| Joseph J. Krivulka | 17 |
| Illya Keith Maher | 17 |
| Mitchell Kaye | 16 |
| Gregory Pepin | 16 |
| Richard P. Burgoon | 16 |
- Stock Market
- Insiders
- Chris Rallis
- Company connections
